Hutchinson Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CarMax
KMX
|
+$7.96M |
| 2 |
Thor Industries
THO
|
+$6.35M |
| 3 |
Ingredion
INGR
|
+$6.34M |
| 4 |
CVS Health
CVS
|
+$2.29M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$265K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.73M |
| 2 |
The Mosaic Company
MOS
|
+$3.4M |
| 3 |
Apple
AAPL
|
+$63.3K |
| 4 |
Pfizer
PFE
|
+$29K |
| 5 |
Boeing
BA
|
+$10.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.87% |
| 2 | Industrials | 15.9% |
| 3 | Healthcare | 15.04% |
| 4 | Financials | 14.13% |
| 5 | Energy | 9.11% |
Similar funds
Hutchinson Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Hutchinson Capital Management held 55 positions worth $359M, up 12% from $322M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Hutchinson Capital Management deployed $18.4M of net new capital in Q3 2018, opening 4 new positions and adding to 27 existing holdings. Its largest new stake was CarMax: 104,314 shares worth $7.79M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $4.73M trimmed.
- Hutchinson Capital Management's largest Q3 2018 buy was CarMax: 104,314 shares worth $7.79M.
- Hutchinson Capital Management added most to CVS Health in Q3 2018, an estimated $2.29M increase.
- Hutchinson Capital Management's biggest Q3 2018 reduction was Merck, cutting an estimated $4.73M.
- Hutchinson Capital Management's ten largest holdings make up 48% of its $359M portfolio in Q3 2018.
- Hutchinson Capital Management opened 4 new positions and closed 0 in Q3 2018.
- Hutchinson Capital Management's portfolio value rose 12% quarter-over-quarter to $359M.
Based on Hutchinson Capital Management's 13F filing for Q3 2018, filed 31 Oct 2018.